Zai Lab Announces Participation in November Investor Conferences
26 10월 2023 - 8:30PM
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that
members of the Company’s senior management team will participate in
the following investor conferences in November 2023:
Jefferies London Healthcare
ConferenceFireside Chat: Wednesday, November 15th at 1:00
p.m. GMTLocation: London
6th Annual Evercore ISI
HealthCONx ConferenceFireside Chat: Wednesday, November
29th at 1:45 p.m. ESTLocation: Miami
A live webcast of the presentations will be available on the
Investor Relations page of Zai Lab’s website at
ir.zailaboratory.com/webcasts-presentations and archived replays
will be available for up to 90 days following the completion of
each event.
About Zai Lab
Zai Lab (NASDAQ: ZLAB; HKEX: 9688) is an innovative,
research-based, commercial-stage biopharmaceutical company based in
China and the United States. We are focused on discovering,
developing, and commercializing innovative products that address
medical conditions with significant unmet needs in the areas of
oncology, autoimmune disorders, infectious disease, and
neuroscience. Our goal is to leverage our competencies and
resources to positively impact human health in China and
worldwide.
For additional information about Zai Lab, including our
products, business activities and partnerships, research, and other
events or developments, please visit www.zailaboratory.com or
follow us at www.twitter.com/ZaiLab_Global.
For more information, please contact:
Investor Relations: Christine
Chiou / Lina Zhang+1 (917) 886-6929 / +86 136 8257
6943christine.chiou1@zailaboratory.com / lina.zhang@zailaboratory.com
Media: Shaun Maccoun / Xiaoyu Chen+1 (415)
317-7255 / +86 185 0015 5011shaun.maccoun@zailaboratory.com /
xiaoyu.chen@zailaboratory.com
Source: Zai Lab Limited
Zai Lab (NASDAQ:ZLAB)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Zai Lab (NASDAQ:ZLAB)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024